IBDEI2RN ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46435,1,3,0)
 ;;=3^Chr Diastolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,46435,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,46435,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,46436,0)
 ;;=I27.82^^206^2297^49
 ;;^UTILITY(U,$J,358.3,46436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46436,1,3,0)
 ;;=3^Chr Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,46436,1,4,0)
 ;;=4^I27.82
 ;;^UTILITY(U,$J,358.3,46436,2)
 ;;=^338238
 ;;^UTILITY(U,$J,358.3,46437,0)
 ;;=I50.22^^206^2297^50
 ;;^UTILITY(U,$J,358.3,46437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46437,1,3,0)
 ;;=3^Chr Systolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,46437,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,46437,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,46438,0)
 ;;=I42.0^^206^2297^53
 ;;^UTILITY(U,$J,358.3,46438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46438,1,3,0)
 ;;=3^Dilated Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,46438,1,4,0)
 ;;=4^I42.0
 ;;^UTILITY(U,$J,358.3,46438,2)
 ;;=^5007194
 ;;^UTILITY(U,$J,358.3,46439,0)
 ;;=I10.^^206^2297^54
 ;;^UTILITY(U,$J,358.3,46439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46439,1,3,0)
 ;;=3^Essential Hypertension
 ;;^UTILITY(U,$J,358.3,46439,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,46439,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,46440,0)
 ;;=I50.9^^206^2297^55
 ;;^UTILITY(U,$J,358.3,46440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46440,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,46440,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,46440,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,46441,0)
 ;;=I35.1^^206^2297^60
 ;;^UTILITY(U,$J,358.3,46441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46441,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,46441,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,46441,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,46442,0)
 ;;=I35.0^^206^2297^61
 ;;^UTILITY(U,$J,358.3,46442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46442,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,46442,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,46442,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,46443,0)
 ;;=I35.2^^206^2297^62
 ;;^UTILITY(U,$J,358.3,46443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46443,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,46443,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,46443,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,46444,0)
 ;;=I35.9^^206^2297^58
 ;;^UTILITY(U,$J,358.3,46444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46444,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,46444,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,46444,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,46445,0)
 ;;=I21.4^^206^2297^57
 ;;^UTILITY(U,$J,358.3,46445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46445,1,3,0)
 ;;=3^NSTEMI Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,46445,1,4,0)
 ;;=4^I21.4
 ;;^UTILITY(U,$J,358.3,46445,2)
 ;;=^5007088
 ;;^UTILITY(U,$J,358.3,46446,0)
 ;;=I42.8^^206^2297^46
 ;;^UTILITY(U,$J,358.3,46446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46446,1,3,0)
 ;;=3^Cardiomypathies NEC
 ;;^UTILITY(U,$J,358.3,46446,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,46446,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,46447,0)
 ;;=I20.8^^206^2297^7
 ;;^UTILITY(U,$J,358.3,46447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46447,1,3,0)
 ;;=3^Angina Pectoris NEC
 ;;^UTILITY(U,$J,358.3,46447,1,4,0)
 ;;=4^I20.8
 ;;^UTILITY(U,$J,358.3,46447,2)
 ;;=^5007078
 ;;^UTILITY(U,$J,358.3,46448,0)
 ;;=I42.2^^206^2297^56
 ;;^UTILITY(U,$J,358.3,46448,1,0)
 ;;=^358.31IA^4^2
